,

Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.

Conclusion The pK(a), log P, and intestinal transport mechanisms should be considered when determining which drugs may have altered pharmacokinetics in patients who have undergone RYGB.
PMID: 22095812 [PubMed – in process] (Source: American Journal of Health-System Pharmacy : AJHP)